By Svea Herbst-Bayliss NEW YORK (Reuters) – Activist investor Politan Capital Management said on Thursday that it has economic exposure to 4.5 million shares or 7.5% of biotechnology company Azenta …
Tag:
politan,
-
-
By Svea Herbst-Bayliss BOSTON -Centene Corp reached a deal with activist investment firm Politan Capital Management in which five new directors will join the managed care company’s board and its …